000 | 01964 a2200541 4500 | ||
---|---|---|---|
005 | 20250515034848.0 | ||
264 | 0 | _c20060809 | |
008 | 200608s 0 0 eng d | ||
022 | _a1533-4406 | ||
024 | 7 |
_a10.1056/NEJMoa055068 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBabenko, Andrey P | |
245 | 0 | 0 |
_aActivating mutations in the ABCC8 gene in neonatal diabetes mellitus. _h[electronic resource] |
260 |
_bThe New England journal of medicine _cAug 2006 |
||
300 |
_a456-66 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aATP-Binding Cassette Transporters _xantagonists & inhibitors |
650 | 0 | 4 | _aBirth Weight |
650 | 0 | 4 |
_aDevelopmental Disabilities _xcomplications |
650 | 0 | 4 | _aDiabetes Complications |
650 | 0 | 4 |
_aDiabetes Mellitus _xdrug therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHeterozygote |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypoglycemic Agents _xtherapeutic use |
650 | 0 | 4 | _aInfant, Newborn |
650 | 0 | 4 |
_aInsulin-Secreting Cells _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMutation, Missense |
650 | 0 | 4 | _aPedigree |
650 | 0 | 4 |
_aPotassium Channels _xgenetics |
650 | 0 | 4 |
_aPotassium Channels, Inwardly Rectifying _xantagonists & inhibitors |
650 | 0 | 4 |
_aReceptors, Drug _xantagonists & inhibitors |
650 | 0 | 4 |
_aSulfonylurea Compounds _xtherapeutic use |
650 | 0 | 4 | _aSulfonylurea Receptors |
650 | 0 | 4 |
_aTolbutamide _xpharmacology |
700 | 1 | _aPolak, Michel | |
700 | 1 | _aCavé, Hélène | |
700 | 1 | _aBusiah, Kanetee | |
700 | 1 | _aCzernichow, Paul | |
700 | 1 | _aScharfmann, Raphael | |
700 | 1 | _aBryan, Joseph | |
700 | 1 | _aAguilar-Bryan, Lydia | |
700 | 1 | _aVaxillaire, Martine | |
700 | 1 | _aFroguel, Philippe | |
773 | 0 |
_tThe New England journal of medicine _gvol. 355 _gno. 5 _gp. 456-66 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1056/NEJMoa055068 _zAvailable from publisher's website |
999 |
_c16474054 _d16474054 |